Joint Action Personalised Cancer Medicine opens the door to private sector stakeholders
03 June 2026 by Lieve DESSING (Sciensano)The Joint Action Personalised Cancer Medicine (JA PCM) welcomed industry stakeholders to the webinar " : & ." It was an engaging session in which consortium representatives presented the pilot activities currently underway and shared concrete...